The analysis revealed a negative correlation between GPX4 and PPP2R2A, PPP2R2B, or PPP2R5E expression in HCC patients from the TCGA-LIHC dataset (Figure S3B). This evidence concerns the gene GPX4 and hepatocellular carcinoma.